Cargando…
The Antibody Response to SARS-CoV-2 Infection
BACKGROUND: Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific antibodies has become an important tool, complementing nucleic acid tests (NATs) for diagnosis and for determining the prevalence of coronavirus disease 2019 (COVID-19) in population serosurveys. The magnit...
Autores principales: | Hueston, Linda, Kok, Jen, Guibone, Ayla, McDonald, Damien, Hone, George, Goodwin, James, Carter, Ian, Basile, Kerri, Sandaradura, Indy, Maddocks, Susan, Sintchenko, Vitali, Gilroy, Nicole, Chen, Sharon, Dwyer, Dominic E, O’Sullivan, Matthew V N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499696/ https://www.ncbi.nlm.nih.gov/pubmed/32989419 http://dx.doi.org/10.1093/ofid/ofaa387 |
Ejemplares similares
-
Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine
por: Basile, Kerri, et al.
Publicado: (2022) -
Clinical evaluation of SARS-CoV-2 point-of-care antibody tests
por: Robosa, Roselle S., et al.
Publicado: (2020) -
Development and Validation of an In-House Real-Time Reverse-Transcriptase Polymerase Chain Reaction Assay for SARS-CoV-2 Omicron Lineage Subtyping between BA.1 and BA.2
por: Pham, David, et al.
Publicado: (2022) -
An emergent clade of SARS-CoV-2 linked to returned travellers from Iran
por: Eden, John-Sebastian, et al.
Publicado: (2020) -
Emergent Omicron BR.2.1 sublineage of SARS-CoV-2 in New South Wales, Australia: a subvariant with high fitness but without increased disease severity
por: Howard-Jones, Annaleise R, et al.
Publicado: (2023)